Literature DB >> 22739228

Idiopathic membranous nephropathy: clinical and histologic prognostic features and treatment patterns over time at a tertiary referral center.

Ben Sprangers1, Andrew S Bomback, Scott D Cohen, Jai Radhakrishnan, Anthony Valeri, Glen S Markowitz, Vivette D'Agati, Gerald B Appel.   

Abstract

BACKGROUND: Idiopathic membranous nephropathy (i-MN) is a leading cause of nephrotic syndrome in adults and results in end-stage renal disease in approximately one third of patients. There are few large, long-term US studies evaluating clinical and histologic prognostic factors in i-MN.
METHODS: We describe 132 patients with biopsy-proven i-MN who were followed for a mean period of 68 months at our tertiary referral center from 1977 to 2009, and we analyzed clinical and histologic features that predicted renal outcomes.
RESULTS: The presence of hypertension and treating physician's decision to institute immunosuppression were negative predictors of attaining complete or partial remission. Among clinical variables, impaired renal function (eGFR <60 ml/min/1.73 m(2)) at time of presentation was the only variable at presentation associated with an increased risk of reaching end-stage renal disease. The use of statins and RAAS blockers were protective. The choice of corticosteroids as the initial immunosuppressive agent by referring physicians decreased over time but even in the most recent era (2000-2008) was significant (33%).
CONCLUSION: Renal function at presentation and non-white race were the main predictors of a worse renal outcome. Corticosteroid therapy is still being adopted as first-line therapy in a significant number of patients in this era. The development of guidelines may help clarify the treatment strategies of i-MN.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22739228     DOI: 10.1159/000339628

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  14 in total

1.  Can genetics risk-stratify patients with membranous nephropathy?

Authors:  Andrew S Bomback; Ali G Gharavi
Journal:  J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 10.121

2.  M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy.

Authors:  Elion Hoxha; Sigrid Harendza; Hans Pinnschmidt; Ulf Panzer; Rolf A K Stahl
Journal:  Clin J Am Soc Nephrol       Date:  2014-09-29       Impact factor: 8.237

3.  Serum uric acid is an independent predictor of renal outcomes in patients with idiopathic membranous nephropathy.

Authors:  Ji Zhang; Min Pan; JianNa Zhang; XiaoHan You; Dou Li; Fan Lin; GuoYuan Lu
Journal:  Int Urol Nephrol       Date:  2019-08-28       Impact factor: 2.370

Review 4.  Novel biomarkers in glomerular disease.

Authors:  Yasar Caliskan; Krzysztof Kiryluk
Journal:  Adv Chronic Kidney Dis       Date:  2014-03       Impact factor: 3.620

5.  Hypercholesterolemia Correlates With Glomerular Phospholipase A2 Receptor Deposit and Serum Anti-Phospholipase A2 Receptor Antibody and Predicts Proteinuria Outcome in Idiopathic Membranous Nephropathy.

Authors:  Lei Dong; Yue-Qiang Li; Shui-Ming Guo; Gang Xu; Wang Wei; Min Han
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

6.  Pathological predictors of renal outcomes in nephrotic idiopathic membranous nephropathy with decreased renal function.

Authors:  Yizhi Chen; Li Tang; Zhe Feng; Xueying Cao; Xuefeng Sun; Moyan Liu; Shuwen Liu; Xueguang Zhang; Ping Li; Ribao Wei; Qiang Qiu; Guangyan Cai; Xiangmei Chen
Journal:  J Nephrol       Date:  2014-02-13       Impact factor: 3.902

7.  Long-term renal survival and related risk factors for primary membranous nephropathy in Chinese children: a retrospective analysis of 217 cases.

Authors:  Ren Wang; Meiqiu Wang; Zhengkun Xia; Chunlin Gao; Zhuo Shi; Xiang Fang; Heyan Wu; Yingchao Peng
Journal:  J Nephrol       Date:  2020-08-08       Impact factor: 3.902

8.  The need for improved uptake of the KDIGO glomerulonephritis guidelines into clinical practice in Canada: a survey of nephrologists.

Authors:  Sean Barbour; Monica Beaulieu; Jagbir Gill; Gabriela Espino-Hernandez; Heather N Reich; Adeera Levin
Journal:  Clin Kidney J       Date:  2014-10-24

9.  Treatment pattern in patients with idiopathic membranous nephropathy-practices in Sweden at the start of the millennium.

Authors:  Jennie Lönnbro-Widgren; Johan Mölne; Börje Haraldsson; Jenny Nyström
Journal:  Clin Kidney J       Date:  2016-01-27

10.  Circulating TNF receptors are significant prognostic biomarkers for idiopathic membranous nephropathy.

Authors:  Su Mi Lee; SeungHee Yang; Ran-Hui Cha; Myounghee Kim; Jung Nam An; Jin Ho Paik; Dong Ki Kim; Shin-Wook Kang; Chun Soo Lim; Yon Su Kim; Jung Pyo Lee
Journal:  PLoS One       Date:  2014-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.